High demand for outsourcing of bioprocess validation services and increasing R&D spending in life science industry to drive global bioprocess validation market
According to TechSci Research report, “Global Bioprocess Validation Market By Test Type (Bacterial Retention, Extractables & Leachables, Integrity Testing, Compatibility Testing, Microbiology Testing, Patent Safety Evaluation), By Process Component (Bioreactors, Filter Elements, Freezing and Thawing Process Bags, Media Containers and Bags, Mixing Systems, Transfer Systems), By End User (Contract Development & Manufacturing Organizations (CDMO), Biotechnology, Pharmaceutical Companies), By Region, Forecast & Opportunities, 2025”, the market is expected to undergo robust growth during the forecast period. The market is majorly driven by presence of stringent safety and quality regulations governing product certification and testing across pharmaceutical and biopharmaceutical industries to maintain agreement with Good Manufacturing Practices (GMP). Moreover, advancements in the field of pharmaceutical manufacturing and growing requirement to reduce production cost across pharmaceutical and food companies are acting as major growth factors for global bioprocess validation market. Further, high demand for outsourcing of bioprocess validation services and increasing R&D spending in life science industry are expected to fuel the market growth through 2025.
Additionally, growing use of use of sophisticated facilities in the pharmaceutical industry is acting as one of the key factors for bioprocess validation market growth. Also, increasing demand for bioprocess validation in emerging countries and patent expiries are propelling the market growth. Further, launch of new drugs in the pharmaceutical sector are expected to boost the growth of global bioprocess validation market in the coming years. However, the market is also facing some challenges. Issues associated with extractable and leachable testing are acting as restraining factor for bioprocess validation market growth.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on “Global Bioprocess Validation Market”
The global bioprocess validation market is segmented based on test type, process component, end user and region. Based on test type, the market is segmented into bacterial retention, extractables & leachables, integrity testing, compatibility testing, microbiology testing and patent safety evaluation. Among them, the extractables & leachables segment is anticipated to witness high demand during the forecast period owing to presence of regulatory directives and guidelines regarding the testing of extractables & leachables and increasing risk of product adulterations. Moreover, growing concern related to product safety, purity, identity and quality are also creating the demand for extractables & leachables testing.
Based on process component, global bioprocess validation market is segmented into bioreactors, filter elements, freezing and thawing process bags, media containers and bags, mixing systems and transfer systems. Among them, filter elements segment is expected to undergo fastest growth through 2025 owing to the increasing usage of a variety of filters in bioprocessing. Filter elements ensure the safety and efficacy of biopharmaceutical products, which is creating their high demand in global market.
Major players operating in the global bioprocess validation market include Sartorius Stedim Biotech S.A., Pall Corporation, Eurofins Scientific, SGS S.A., Cobetter Filtration Equipment Co., Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Toxikon Corporation, Meissner Filtration Products, Inc., Doc S.R.L., Hangzhou Anow Microfiltration Co., Ltd., Almac Group, Tianshan Precision Filter Material Co., Ltd. and Porvair plc. The companies are investing a major portion of their sales revenue in R&D activities. They are also focusing on launching superior quality products.
Download Sample Report @
Customers can also request for 10% free customization on this report.
“Asia Pacific is anticipated to serve as a lucrative market for bioprocess validation companies. The reasons can be attributed to growing biopharmaceutical manufacturing capabilities and growing demand for outsourcing bioprocess validation in Asian countries. The region is also witnessing an increase in awareness about the advantages of biopharmaceutical drugs, especially in developing nations like India and China. Apart from that, favorable government initiatives in various APAC countries to promote the growth of pharmaceutical & biotechnology industries is supporting the bioprocess validation market growth,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Bioprocess Validation Market By Test Type (Bacterial Retention, Extractables & Leachables, Integrity Testing, Compatibility Testing, Microbiology Testing, Patent Safety Evaluation), By Process Component (Bioreactors, Filter Elements, Freezing and Thawing Process Bags, Media Containers and Bags, Mixing Systems, Transfer Systems), By End User (Contract Development & Manufacturing Organizations (CDMO), Biotechnology, Pharmaceutical Companies), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global bioprocess validation market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global bioprocess validation market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017